ANI Pharmaceuticals | ANIP - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
ANI Pharmaceuticals USD 278.11M 7.56M 2025-12
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Perrigo USD 1.01B 132.4M 2025-12
Sun Pharmaceuticals INR 234.15B 52.21B 2025-09
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12